Role of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers

Mascaretti, Federica; Haider, Salman; Amoroso, Chiara; Caprioli, Flavio; Ramai, Daryl; Ghidini, Michele

doi:10.1007/s12029-024-01021-x

Cited by 2 publications

(2 citation statements)

References 179 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Intake of probiotics and prebiotics is being researched to enhance therapeutic results and lessen side effects related to anticancer medication. [55] The EVs and CFS of the L. crispatus strain RIGLD-1 are possible therapeutic agents to combat inflammation caused by H. pylori. [56] One possible nanovaccine to be used in an oral vaccination against H. pylori infection is alginate/pCI-neo-UreH.…”

Section: Current Treatment Options Studies Referencesmentioning

confidence: 99%

“…Interventions such as the use of probiotics, prebiotics, or antibiotics can alter the gut microbiota. GC is associated with dysbiosis and immunological dysregulation caused by alterations in the normal gut microbiota [ 55 ]. Traditional antibiotic therapy in conjunction with probiotics and postbiotics is currently receiving much attention for the treatment of H. pylori infection.…”

Section: Treatmentmentioning

confidence: 99%

See 1 more Smart Citation

Helicobacter pylori Infection in Patients with Gastric Cancer: A 2024 Update

Burz,

Pop,

Silaghi

et al. 2024

Cancers

View full text Add to dashboard Cite

Numerous studies have been performed on Helicobacter pylori infection because of the high death rate linked to this illness and gastric cancer. An update on the key developments in recent years in the investigation of Helicobacter pylori and gastric cancer is the goal of this review. Using the search term “Helicobacter pylori, gastric cancer”, the PubMed database was searched. Only papers published in 2024 fulfilled the inclusion criteria. Because case report papers were not part of our investigation, they satisfied the exclusion criteria. Most of the research on the variable genes of Helicobacter pylori is guided by genetics to determine potential treatments. Studies on clinical treatments for the eradication of H. pylori with promising therapeutic options are needed. We found the fewest studies related to the immunopathology of H. pylori infection, which is still unknown. In conclusion, priority should be given to this kind of research.

show abstract

Section: Current Treatment Options Studies Referencesmentioning

confidence: 99%

Section: Treatmentmentioning

confidence: 99%